Preclinical biotech developing therapies for solid tumors by targeting ferroptosis.
Industry: Health Care
Latest Trade: $0.51 +0.27 (+119.1%)
First Day Return: -13.0%
Return from IPO: -94.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/27/2021 |
Offer Price | $4.00 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 3.8 |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/11/2022 |
Offer Price | $4.00 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 3.8 |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
ThinkEquity |
Company Data | |
---|---|
Headquarters | Bridgewater, NJ, United States |
Founded | 2017 |
Employees at IPO | 2 |
Website www.hillstreambio.com |